Pharmacokinetic interaction study evaluating the effect of BMS-275291 on the pharmacokinetics of paclitaxel and carboplatin in patients with advanced or metastatic non-small cell lung cancer (NSCLC).

被引：0
|
作者：
Malik, SM
Hwang, JJ
Belani, CP
Galbraith, S
Bai, S
Rizvi, NA
机构：
[1] Lombardi Canc Ctr, Washington, DC USA
[2] Univ Pittsburgh, Inst Canc, Pittsburgh, PA USA
[3] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7309
引用
收藏
页码：693S / 693S
页数：1
相关论文
共 50 条
  • [31] Carboplatin and paclitaxel (Taxol®) for non-small cell lung cancer [NSCLC], a standard regimen?
    Pralong-Kohler, J
    Stupp, R
    Monnerat, C
    Bauer, J
    Stalder, M
    Perey, L
    Leyvraz, S
    ANNALS OF ONCOLOGY, 1998, 9 : 87 - 87
  • [32] Phase I and pharmacokinetic study of paclitaxel and irinotecan for patients with advanced non-small cell lung cancer
    Kasai, T
    Oka, M
    Soda, H
    Tsurutani, J
    Fukuda, M
    Nakamura, Y
    Kawabata, S
    Nakatomi, K
    Nagashima, S
    Takatani, H
    Fukuda, M
    Kinoshita, A
    Kohno, S
    EUROPEAN JOURNAL OF CANCER, 2002, 38 (14) : 1871 - 1878
  • [33] Safety and efficacy of AMG 655 in combination with paclitaxel and carboplatin (PC) in patients with advanced non-small cell lung cancer (NSCLC)
    Paz-Ares, L.
    Sanchez Torres, J. M.
    Diaz-Padilla, I.
    Links, M.
    Reguart, N.
    Boyer, M.
    Wiezorek, J.
    Sabin, T.
    Pan, Y.
    Van Meerbeeck, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [34] Carboplatin/nab-Paclitaxel and Pembrolizumab for Patients with Advanced Non-Small Cell Lung Cancer (NSCLC): Phase 1 Results
    Gentzler, R. D.
    Mohindra, N. A.
    Hanna, N.
    Chae, Y. K.
    Jalal, S. I.
    Hall, R.
    Villaflor, V. M.
    Reckamp, K. L.
    Koczywas, M.
    Sullivan, D.
    Wood, L.
    Patel, J. D.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 98 (01): : 236 - 236
  • [35] A phase 1 study of linifanib in combination with carboplatin/paclitaxel as first-line treatment of Japanese patients with advanced or metastatic non-small cell lung cancer (NSCLC)
    Hidehito Horinouchi
    Noboru Yamamoto
    Hiroshi Nokihara
    Takeshi Horai
    Makoto Nishio
    Fumiyoshi Ohyanagi
    Atsushi Horiike
    Kazuhiko Nakagawa
    Masaaki Terashima
    Takafumi Okabe
    Hiroyasu Kaneda
    Mark D. McKee
    Dawn M. Carlson
    Hao Xiong
    Tomohide Tamura
    Cancer Chemotherapy and Pharmacology, 2014, 74 : 37 - 43
  • [36] A phase 1 study of linifanib in combination with carboplatin/paclitaxel as first-line treatment of Japanese patients with advanced or metastatic non-small cell lung cancer (NSCLC)
    Horinouchi, Hidehito
    Yamamoto, Noboru
    Nokihara, Hiroshi
    Horai, Takeshi
    Nishio, Makoto
    Ohyanagi, Fumiyoshi
    Horiike, Atsushi
    Nakagawa, Kazuhiko
    Terashima, Masaaki
    Okabe, Takafumi
    Kaneda, Hiroyasu
    McKee, Mark D.
    Carlson, Dawn M.
    Xiong, Hao
    Tamura, Tomohide
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014, 74 (01) : 37 - 43
  • [37] A randomized phase III trial comparing ionafarnib/carboplatin/paclitaxel versus carboplatin/paclitaxel (CP) in chemotherapy-naive patients with advanced or metastatic non-small cell lung cancer (NSCLC)
    Blumenschein, G
    Ludwig, C
    Thomas, G
    Tan, E
    Fanucchi, M
    Santoro, A
    Crawford, J
    Breton, J
    O'Brien, M
    Khuri, F
    LUNG CANCER, 2005, 49 : S30 - S30
  • [38] Phase II study of carboplatin and weekly paclitaxel in advanced non-small cell lung cancer
    Nakadate, Megumi
    Yamazaki, Koichi
    Konishi, Jun
    Kinoshita, Ichiro
    Sukoh, Noriaki
    Harada, Masao
    Akie, Kenji
    Ogura, Shigeaki
    Ishida, Takashi
    Munakata, Mitsuru
    Dosaka-Akita, Hirotoshi
    Isobe, Hiroshi
    Nishimura, Masaharu
    ANTICANCER RESEARCH, 2006, 26 (5B) : 3767 - 3772
  • [39] A dose-escalating and pharmacokinetic study of weekly combination chemotherapy with paclitaxel and carboplatin for unresectable non-small cell lung cancer (NSCLC)
    Kudo, Hiroyasu
    ANNALS OF ONCOLOGY, 2004, 15 : 180 - 181
  • [40] A phase II study of biweekly paclitaxel and carboplatin in elderly patients with advanced non-small cell lung cancer
    Soejima, Kenzo
    Naoki, Katsuhiko
    Ishioka, Kota
    Nakamura, Morio
    Nakatani, Michie
    Kawada, Ichiro
    Watanabe, Hideo
    Nakachi, Ichiro
    Yasuda, Hiroyuki
    Satomi, Ryosuke
    Nakayama, Sohei
    Yoda, Satoshi
    Ikemura, Sinnosuke
    Terai, Hideki
    Sato, Takashi
    Ohgino, Keiko
    Arai, Daisuke
    Tani, Tetsuo
    Kuroda, Aoi
    Nishino, Makoto
    Betsuyaku, Tomoko
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2015, 75 (03) : 513 - 519
12345